While most of the world bans direct-to-consumer advertising for prescription drugs, the FDA said Friday that it’s launching a study into how people might perceive such ads that include information on secondary endpoints that are not part of an approved indication.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,